Apelin, prediabetes and atherosclerosis

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 8, 2011, Pages 457-458

  Tasci, I ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN;

ADIPOSE TISSUE; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ATHEROSCLEROSIS; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; REFERENCE VALUES; RESEARCH DESIGN;

EID: 80052693992     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0031-1284338     Document Type: Letter

References (10)

1. Bots M L , Westerink J , Rabelink T J et al. Assessment of fl ow-mediated vasodilatation (FMD) of the brachial artery: eff ects of technical aspects of the FMD measurement on the FMD response . Eur Heart J 2005 ; 26 : 363-368
2. Erdem G , Dogru T , Tasci I et al. Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus . Exp Clin Endocrinol Diabetes 2008 ; 116 : 289-292
3. Graham I , Atar D , Borch-Johnsen K et al. European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation ope (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of eneral Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by Invited experts). Eur J Cardiovasc Prev Rehabil 2007 14 ( Suppl 2 ) : E1-E40
4. Lucio M , Fekete A , Weigert C et al. Insulin sensitivity is refl ected by characteristic metabolic fi ngerprints - a Fourier transform mass spectrometric non-targeted metabolomics approach . PLoS One 2010 ; 5 : e13317
5. Radikova Z , Koska J , Huckova M et al. Insulin sensitivity indices: a proposal of cut-off points for simple identifi cation of insulin-resistant subjects . Exp Clin Endocrinol Diabetes 2006 ; 114 : 249-256
6. Ringström C, Nitert M D, Bennet H et al. Apelin is a novel islet peptide . Regul Pept 2010 ; 162 : 44-51
7. Rittig K , Hildebrandt U , Thamer C et al. Apelin Serum Levels are not Associated with Early Atherosclerosis or Fat Distribution in Young Subjects with Increased Risk for Type 2 Diabetes . Exp Clin Endocrinol Diabetes 2011 DOI: http://dx.doi.org/10.1055/s-0030-1268466
8. Sonmez A , Celebi G , Erdem G et al. Plasma apelin and ADMA Levels in patients with essential hypertension . Clin Exp Hypertens 2010 ; 32 : 179-183
9. Tasci I , Dogru T , Naharci I et al. Plasma apelin is lower in patients with elevated LDL-cholesterol . Exp Clin Endocrinol Diabetes 2007 ; 115 : 428-432
10. Zhang Y , Shen C , Li X et al. Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people . Diabetes Care 2009 ; 32 : e150